Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beaulieu

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 18, 2014
A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS)Pierre L Beaulieu, Josie De Marte, Michel Garneau, et al.
Brachytherapy|December 16, 2025
A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapyF Lacroix, E Poulin, C Bélanger, et al.
BMC Neurology|February 1, 2014
The utility of exome sequencing for genetic diagnosis in a familial microcephaly epilepsy syndromeLaura M McDonell, Jodi Warman Chardon, Jeremy Schwartzentruber, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2010
Benzimidazole Thumb Pocket I finger-loop inhibitors of HCV NS5B polymerase: improved drug-like properties through C-2 SAR in three sub-seriesPierre L Beaulieu, Nathalie Dansereau, Jianmin Duan, et al.
Medical Physics|June 24, 2009
Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implantC Furstoss, B Reniers, M J Bertrand, et al.
Journal of Medicinal Chemistry|June 5, 2013
Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemistsSteven R LaPlante, Rebekah Carson, James Gillard, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicityPierre L Beaulieu, Gordon Bolger, Dan Deon, et al.
Learning Health Systems|April 18, 2025
Setting the foundation for a national collaborative learning health system in acute TBI rehabilitation: CARE4TBI Year 1 experienceCynthia L Beaulieu, Jennifer Bogner, Chad Swank, et al.
Geromedicine|June 12, 2026
Excessive GABAergic activity in striatal and frontal cortical regions more than dopaminergic functions are related to daytime sleepiness in Parkinson's disease: An exploratory 11C-flumazenil PET studyRobert Vangel, Stiven Roytman, Madhusudan Reddy, et al.
The Journal of Biological Chemistry|September 29, 2005
Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymeraseGeorge Kukolj, Graham A McGibbon, Ginette McKercher, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
Bioorganic & Medicinal Chemistry Letters|December 18, 2014
A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS)Pierre L Beaulieu, Josie De Marte, Michel Garneau, et al.
Brachytherapy|December 16, 2025
A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapyF Lacroix, E Poulin, C Bélanger, et al.
BMC Neurology|February 1, 2014
The utility of exome sequencing for genetic diagnosis in a familial microcephaly epilepsy syndromeLaura M McDonell, Jodi Warman Chardon, Jeremy Schwartzentruber, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2010
Benzimidazole Thumb Pocket I finger-loop inhibitors of HCV NS5B polymerase: improved drug-like properties through C-2 SAR in three sub-seriesPierre L Beaulieu, Nathalie Dansereau, Jianmin Duan, et al.
Medical Physics|June 24, 2009
Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implantC Furstoss, B Reniers, M J Bertrand, et al.
Journal of Medicinal Chemistry|June 5, 2013
Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemistsSteven R LaPlante, Rebekah Carson, James Gillard, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicityPierre L Beaulieu, Gordon Bolger, Dan Deon, et al.
Learning Health Systems|April 18, 2025
Setting the foundation for a national collaborative learning health system in acute TBI rehabilitation: CARE4TBI Year 1 experienceCynthia L Beaulieu, Jennifer Bogner, Chad Swank, et al.
Geromedicine|June 12, 2026
Excessive GABAergic activity in striatal and frontal cortical regions more than dopaminergic functions are related to daytime sleepiness in Parkinson's disease: An exploratory 11C-flumazenil PET studyRobert Vangel, Stiven Roytman, Madhusudan Reddy, et al.
The Journal of Biological Chemistry|September 29, 2005
Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymeraseGeorge Kukolj, Graham A McGibbon, Ginette McKercher, et al.
Pageof 19